Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margitta Retz

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Der Urologe. Ausg. A|May 20, 2021
[Muscle-invasive bladder cancer]Jakob Büchler, Jürgen E Gschwend, Margitta Retz, et al.
Aktuelle Urologie|March 28, 2018
[Immunotherapy with checkpoint inhibitors in local advanced and metastatic urothelial carcinoma]Kurt Miller, Jürgen E Gschwend, Axel Merseburger, et al.
Urologia Internationalis|August 24, 2020
Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II InstrumentPhilipp Maisch, Margitta Retz, Jürgen E Gschwend, et al.
Expert Review of Anticancer Therapy|December 31, 2002
Managing locally advanced bladder cancerJan Lehmann, Margitta Retz, Stefan Siemer, et al.
Aktuelle Urologie|October 27, 2025
[Therapy Management of PARP Inhibitor Combinations in mCRPC Clinical Practice]Margitta Retz, Angelika Borkowetz, Katja Wittenzellner, et al.
Der Urologe. Ausg. A|January 28, 2022
[Metastatic urothelial carcinoma-guideline-based therapy and new options]Günter Niegisch, Gunhild von Amsberg, Marc Rehlinghaus, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2006
Long-term survival under maintenance gemcitabine chemotherapy for metastatic transitional cell carcinomaJan Lehmann, Margitta Retz, Stefan Siemer, et al.
Aktuelle Urologie|June 27, 2019
[50 years of systemic therapy of urinary bladder cancer]Margitta Retz, Gunhild von Amsberg, Thomas Horn, et al.
European Urology|December 31, 2010
Long-term follow-up of bladder cancer patients with disseminated tumour cells in bone marrowMargitta Retz, Jens Rotering, Roman Nawroth, et al.
BMC Cancer|June 5, 2015
Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experienceMargitta Retz, Patrick de Geeter, Peter J Goebell, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Der Urologe. Ausg. A|May 20, 2021
[Muscle-invasive bladder cancer]Jakob Büchler, Jürgen E Gschwend, Margitta Retz, et al.
Aktuelle Urologie|March 28, 2018
[Immunotherapy with checkpoint inhibitors in local advanced and metastatic urothelial carcinoma]Kurt Miller, Jürgen E Gschwend, Axel Merseburger, et al.
Urologia Internationalis|August 24, 2020
Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II InstrumentPhilipp Maisch, Margitta Retz, Jürgen E Gschwend, et al.
Expert Review of Anticancer Therapy|December 31, 2002
Managing locally advanced bladder cancerJan Lehmann, Margitta Retz, Stefan Siemer, et al.
Aktuelle Urologie|October 27, 2025
[Therapy Management of PARP Inhibitor Combinations in mCRPC Clinical Practice]Margitta Retz, Angelika Borkowetz, Katja Wittenzellner, et al.
Der Urologe. Ausg. A|January 28, 2022
[Metastatic urothelial carcinoma-guideline-based therapy and new options]Günter Niegisch, Gunhild von Amsberg, Marc Rehlinghaus, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2006
Long-term survival under maintenance gemcitabine chemotherapy for metastatic transitional cell carcinomaJan Lehmann, Margitta Retz, Stefan Siemer, et al.
Aktuelle Urologie|June 27, 2019
[50 years of systemic therapy of urinary bladder cancer]Margitta Retz, Gunhild von Amsberg, Thomas Horn, et al.
European Urology|December 31, 2010
Long-term follow-up of bladder cancer patients with disseminated tumour cells in bone marrowMargitta Retz, Jens Rotering, Roman Nawroth, et al.
BMC Cancer|June 5, 2015
Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experienceMargitta Retz, Patrick de Geeter, Peter J Goebell, et al.
Pageof 10